Glycopyrrolate for Anastomtic Dehiscence in Esophageal Atresia
With Dr. Abdul Raoof Lamoshi · hosted by Dr. Todd Ponsky · StayCurrentMD
Part of
Esophageal Atresia 27 items
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
QUAD Conference Commercial
1 min · Published May 2022
Video
Esophageal Atresia & Tracheoesophageal Fistula (EA/TEF) Types Explained for Pediatric Surgery
2 min · Published Sep 2026
Video
Hot New Topics from The Journal Of Pediatric Surgery: Update Course 2017
Dr. Todd Ponsky · 27 min · Published Aug 2017
Video
Esophageal Atresia
39 min · Published Nov 2018
Podcast
Case Based Journal Review: Esophageal Atresia in 2022
17 min · Published Aug 2022
Video
Thoracoscopic TEF Repair, Is It Really Better Than Open? Update Course 2018
18 min · Published Aug 2018
Only a few other public items share this expert — go deeper there →
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026
Video
Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients
1 min · Published May 2026
What the experts said
The study was a very well done randomized controlled trial with a very good sample size
The results were both statistically and clinically significant
Glycopyrrolate is a novel treatment that can have substantial effect on the complicated problem of anastomotic leak after esophageal atresia repair
The study was a prospective randomized control trial studying the effect of glycopyrolate on patients that had leak after esophageal atresia repair
There were 297 patients over a 10 year period that underwent esophageal atresia repair
Of the 297 patients, there were 42 leaks, approximately 14%
The 42 patients with leaks were prospectively randomized into two groups of 21 each, one receiving glycopyrrolate and the other receiving placebo (saline)
The observer was blinded to which treatment group the patient was in
Chest tube output was 124 mL in the glycopyrrolate treatment group compared to 370 mL in the placebo group
Leak resolution was accomplished in 76% of the glycopyrrolate treatment group compared to 29% of the placebo group
Oral feeding was achieved in 71% of the glycopyrrolate treatment group compared to only 14% of the placebo group